Rapid Quantification of C. difficile Glutamate Dehydrogenase and Toxin B (TcdB) with a NanoBiT Split-Luciferase Assay

[Image: see text] C. difficile infection (CDI) is a leading healthcare-associated infection with a high morbidity and mortality and is a financial burden. No current standalone point-of-care test (POCT) is sufficient for the identification of true CDI over a disease-free carriage of C. difficile, so...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamson, Hope, Ajayi, Modupe O., Gilroy, Kate E., McPherson, Michael J., Tomlinson, Darren C., Jeuken, Lars J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201815/
https://www.ncbi.nlm.nih.gov/pubmed/35634999
http://dx.doi.org/10.1021/acs.analchem.1c05206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201815/
https://www.ncbi.nlm.nih.gov/pubmed/35634999
http://dx.doi.org/10.1021/acs.analchem.1c05206

Ejemplares similares